Indian Journal of Surgery

, Volume 76, Issue 4, pp 282–287 | Cite as

A Comparative Study of Paediatric Thermal Burns Treated with Topical Heparin and Without Heparin

  • T. S. Venkatachalapathy
Original Article


Following reports of heparin use in burn treatment, an ethics-committee-approved prospective randomized study with controls compared results obtained using traditional usual burn treatment without heparin with results in similar patients similarly treated with heparin added topically. The subjects were 100 consecutive burn patients (age <15 years) with second-degree superficial and deep burns of 5–45 % total body surface area size. Two largely similar cohort groups—a control group (C) and a heparin group (H) with 50 subjects per group—were randomly treated. The 50 control group patients received traditional routine treatment, including topical antimicrobial cream, debridement, and, when needed, skin grafts in the early postburn period. The 50 heparin group patients, without topical cream, were additionally treated, starting on day 1 postburn, with 200 IU/ml sodium aqueous heparin solution USP (heparin) dripped on the burn surfaces and inserted into the blisters two to four times a day for 1–2 days, and then only on burn surfaces for a total of 5–7 days, before skin grafting, when needed. Thereafter, control and heparin group treatment was similar. It was found that the heparin patients complained of less pain and received less pain medicine than the control patients. The heparin group needed fewer dressings and oral antibiotics than the control group. The 50 heparin group patients had 4 skin graftings (8 %), while the 50 control group patients had 10 (20 %). Five control group patients died (mortality 10 %). No heparin group patients died. The number of days in hospital for the heparin group versus control group was significantly less (overall P < 0.0001): 58 % of heparin group patients were discharged within 10 days versus 6 % of control group patients; 82 % of heparin group patients were out in 20 days versus 14 % of control group patients; 98 % of the heparin group versus 44 % of the control group were out in 30 days; and while 100 % of heparin group patients were discharged by day 40, 56 % of the control group required up to another 10 days. Burns in heparin group patients healed on average in 15 days (maximum period 37 days) versus an average of 25 days (maximum >48 days) in control group patients (P < 0.0006). Procedures and costs in the heparin group were much reduced compared with the control group. Differences between the heparin and control groups are presented for the sake of comparison. It was concluded that heparin applied topically for 5–7 days improved burn treatment: it reduced pain, pain medicine, dressings, and use of antibiotics; it significantly reduced IV fluids (P < 0.04), days in hospital (P < 0.0001), and healing time (P < 0.0006); and it reduced skin grafts, mortality, and costs.


Thermal burns IInd degree burns Topical heparin 


  1. 1.
    Saliba MJ (2001) Heparin in the treatment of burns: a review. Burns 27:348–357CrossRefGoogle Scholar
  2. 2.
    Reyes A, Astiazaran JA, Chavez CC, Jaramilla F (2001) Burns treated with and without heparin: controlled use in a thermal disaster. Ann Burns Fire Disasters 14:183–191Google Scholar
  3. 3.
    Saliba MJ Jr (1997) The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life. Acta Chir Plast 39:13–16PubMedGoogle Scholar
  4. 4.
    (Oral presentation) Ramakrishnan KM (2002) Recent concepts in burn wound healing. National C.M.E. in Burns and Plastic Surgery, Session on Burns, March 2002, Kanchi Kamakoti Child Trust Hospital, Chennai, India. Sponsored by National Academy of Medical Sciences (India), New Delhi, 1:1–4, 2002Google Scholar
  5. 5.
    Stoddard FJ, Sheridan RL, Saxe GN (2002) Treatment of pain in acutely burned children. J Burn Care Rehabil 23(2):135–156PubMedCrossRefGoogle Scholar
  6. 6.
    Stoddard FJ, Saxe G, Ronfeldt H (2006) Acutestress symptoms in young children with burns. J Am Acad Child Adolesc Psychiatry 45(1):87–93PubMedCrossRefGoogle Scholar
  7. 7.
    Tarnowski KJ, Rasnake LK, Drabman RS (1987) Behavioural assessment and treatment of pediatric burn injuries: a review. Behav Ther 18:417–441CrossRefGoogle Scholar
  8. 8.
    Oremus M, Hanson M (2006) The uses of heparin to treat burn injury. Agency for Healthcare Research and Quality U.S. Department of Health and Human Services AHRQ Publication No. 07-E004, December 2006Google Scholar
  9. 9.
    Drake JE, Stoddard FJ Jr, Murphy JM (2006) Trauma severity influences acute stress in young burned children. J Burn Care Res 27(2):174–182PubMedCrossRefGoogle Scholar
  10. 10.
    Troshvia K, Dimitrov R (2001) Application of heparin in the local treatment of burns. Acta Chir Plast 43:143–144Google Scholar
  11. 11.
    Srivastava JL, Ramesh Babu K, Tewari VK (1988) Heparin in the management of extensive burns. Indian J Plast Surg 21(1):7–12Google Scholar
  12. 12.
    Saliba MJ Jr, Dempsey WC, Kruggel JL (1973) Large burns in humans, treatment with heparin. JAMA 225:261–269PubMedCrossRefGoogle Scholar
  13. 13.
    Saliba MJ Jr, Saliba RJ (1974) Heparin in burns: dose-related and dose-dependent effects. Thrombos Diasthes Haemorrh 33:113–123Google Scholar
  14. 14.
    Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J (1980) Mast cell heparin stimulates migration of capillary endothelial cell in vitro. J Exp Med 152:931PubMedCrossRefGoogle Scholar
  15. 15.
    Macaig T (1984) Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 225:932CrossRefGoogle Scholar
  16. 16.
    Folkman J, Shing Y (1992) Control of angiogenesis by heparin and other sulphated polysaccharides. Adv Exp Med Biol 313:355–364PubMedCrossRefGoogle Scholar
  17. 17.
    Zapat-Sirvant RL, Hansbrough JF, Greenleaf GE (1994) Reduction of bacterial translocation and intestinal structure alterations by heparin in a murine burn injury model. J Trauma 36:1–6CrossRefGoogle Scholar
  18. 18.
    Ferrao AV, Mason RM (1993) The effect of heparin on cell proliferation and type I collagen synthesis by adult human dermal fibroblasts. Biochem Biophys Acta 1180:225–230PubMedGoogle Scholar
  19. 19.
    Ehrlich HR, Griswold TR, Rajaratanam JBM (1986) Studies on vascular smooth muscle cells and dermal fibroblast in collagen matrices: effect of heparin. Exp Cell Res 164:154–162PubMedCrossRefGoogle Scholar
  20. 20.
    McCarthy DW, Downing MT, Brigstock DR (1996) Production of heparin-binding epidermal growth factor-like growth factor at sites of thermal injury in paediatric patients. J Invest Dermatol 106:49–56PubMedCrossRefGoogle Scholar
  21. 21.
    Venakatachalapathy TS, Mohankumar S, Saliba MJ (2007) A comparative study of thermal burns treated with and without topical heparin. Ann Burns Fire Disasters 4:189–198Google Scholar

Copyright information

© Association of Surgeons of India 2012

Authors and Affiliations

  1. 1.Indira Gandhi Govt General Hospital and Post Graduate InstitutePuducherryIndia

Personalised recommendations